🍪 CompoundTalk uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsClinical Trials & ResearchEcnoglutide, mazdutide, and other emerging GLP-1 pipeline agents Page 4

Ecnoglutide, mazdutide, and other emerging GLP-1 pipeline agents

TrialTracker_MD Thu, Jun 4, 2026 at 9:47 AM 19 replies 418 viewsPage 4 of 4
sarah_TO
Member
278
1,234
Sep 2024
Toronto, CA
Jun 6, 2026 at 11:57 AM#16
LindaRN_retired said:
The honest answer is that the effect is real, the magnitude is contested, and the individual variation is larger than either.

Adding a me-too, because a thread of one person's experience is not much use. I had assumed I was the exception until I read this.

27 2andrew_nyc, Dr.EndoEP, GraceAZ_72 and 24 others
Reply Quote Save Share Report
mel_PDX
Member
189
890
Dec 2024
Portland, OR
Jun 6, 2026 at 6:30 PM#17
Dr.PeteFamMed said:
Say what you would expect to see if you were wrong, before you look.

That reframing is the part I needed.

Last edited: Jun 7, 2026 at 12:30 AM
26 1Dr.KarenChen, Dr.NateNeph, PharmD_Rodriguez and 23 others
Reply Quote Save Share Report
NurseAsh_DET
Member
356
1,567
Sep 2024
Detroit, MI
Jun 7, 2026 at 1:03 AM#18

From the other side of the consultation, briefly. It is worth asking what the claim would look like if it were false. If nothing would look different, it is not a claim about the world and no amount of discussion will settle it.

25 0BrianDallas92, labquiet_amy, emily_PDX and 22 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
emma_london
Member
312
1,456
Oct 2024
London, UK
Jun 7, 2026 at 7:37 AM#19
NurseAsh_DET said:
It is worth asking what the claim would look like if it were false.

Mine went the same way, slower.

Last edited: Jun 7, 2026 at 1:37 PM
24 24JessicaM_2024, TomFromTexas, mike.trainer_LA and 21 others
Reply Quote Save Share Report
mike_mod
Moderator
7,234
19,823
Nov 2023
New York
Online
Jun 7, 2026 at 2:11 PM#20

Moderator note: the sourcing question belongs in the vendor section and has been split out. Thread quality here is what the rules are for. Keep it up.

2 2PurityPaulOR, MaxMetOK
Reply Quote Save Share Report

Similar Threads

FLOW trial: semaglutide renal outcomes — NEJM publication review14 replies
SELECT trial: semaglutide 2.4mg cardiovascular outcomes — 4yr data9 replies
TRIUMPH program (retatrutide) — Phase 3 trial design and endpoints13 replies
Orforglipron ATTAIN trials — oral non-peptide GLP-1 agonist8 replies
CagriSema (amylin + semaglutide) — REDEFINE Phase 3 results20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register